ANIP ANI Pharmaceuticals Inc

NASDAQ
$71.65

ANI Pharmaceuticals Inc (ANIP) is confirmed to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is $1.80 per share.

ANI Pharmaceuticals Beat Consensus Estimates, Revises Guidance
Thursday, November 5, 2026 · 6:51 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 6:50 AM ET
Earnings Whisper
-
vs $1.80
Rev est $280.17M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $73.81

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About ANI Pharmaceuticals Inc

ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary develops, manufactures and markets branded and generic prescription pharmaceuticals products.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Held By 3 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.